{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:42:18Z","timestamp":1761968538003,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.survophthal.2011.10.002","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T07:16:26Z","timestamp":1331018186000},"page":"565-572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Blindness, Weakness, and Tingling"],"prefix":"10.1016","volume":"57","author":[{"given":"Damien","family":"Biotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Vignal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Sharshar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Gout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison N.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2011.10.002_bib1","first-page":"565","article-title":"Criteria for diagnosis of Guillain-Barre syndrome","volume":"3","year":"1978","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2011.10.002_bib2","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2169\/internalmedicine.47.1224","article-title":"Guillain-Barr\u00e9 syndrome with optic neuritis and a focal lesion in the central white matter following Epstein-Barr virus infection","volume":"47","author":"An","year":"2008","journal-title":"Intern Med"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2011.10.002_bib3","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barre syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2011.10.002_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/bjo.60.1.58","article-title":"Optic neuritis in the Landry-Guillain-Barr\u00e9-Strohl syndrome","volume":"60","author":"Behan","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.10.002_bib5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/bjo.87.9.1185","article-title":"Optic neuritis in anti-GQ1b positive recurrent Miller Fisher syndrome","volume":"87","author":"Chan","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.10.002_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(96)01123-7","article-title":"Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome","volume":"745","author":"Chiba","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.survophthal.2011.10.002_bib7","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/brain\/awh585","article-title":"Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barre syndrome","volume":"128","author":"Cochen","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2011.10.002_bib8","first-page":"249","article-title":"[Important vision disorder in Guillain-Barr\u00e9 syndrome]","volume":"73","author":"de Margerie","year":"1973","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"10.1016\/j.survophthal.2011.10.002_bib9","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(97)24050-X","article-title":"Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barr\u00e9 syndrome","volume":"350","author":"Farcas","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2011.10.002_bib10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.nmd.2006.03.006","article-title":"Demyelinating polyneuropathy in Leber hereditary optic neuropathy","volume":"16","author":"Gilhuis","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.survophthal.2011.10.002_bib11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00415-004-0441-0","article-title":"Bilateral optic neuritis and Guillain-Barre syndrome following an acute Mycoplasma pneumoniae infection","volume":"251","author":"Ginestal","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.survophthal.2011.10.002_bib12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.58.6.913","article-title":"Early electrodiagnostic findings in Guillain-Barr\u00e9 syndrome","volume":"58","author":"Gordon","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.survophthal.2011.10.002_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/pgmj.63.743.735","article-title":"The clinical use of cerebrospinal fluid studies in demyelinating neurological diseases","volume":"63","author":"Harrington","year":"1987","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.survophthal.2011.10.002_bib14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1468-1331.2003.00659.x","article-title":"Post-infectious central and peripheral nervous system diseases in patient with Devic's disease and Guillain-Barr\u00e9 syndrome","volume":"10","author":"Hawley","year":"2003","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.survophthal.2011.10.002_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1445-5994.1998.tb02093.x","article-title":"Guillain-Barr\u00e9 syndrome and optic neuritis after mycoplasma pneumoniae infection","volume":"28","author":"Henderson","year":"1998","journal-title":"Aust NZ J Med"},{"key":"10.1016\/j.survophthal.2011.10.002_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008630.pub2","article-title":"Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barr\u00e9 syndrome","author":"Hughes","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 2","key":"10.1016\/j.survophthal.2011.10.002_bib17","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain-Barr\u00e9 syndrome","volume":"176","author":"Hughes","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.survophthal.2011.10.002_bib18","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","author":"Hughes","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2011.10.002_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1085-9489.2005.10313.x","article-title":"Guillain-Barr\u00e9 syndrome with optic neuritis and cytomegalovirus infection","volume":"10","author":"Igarashi","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.survophthal.2011.10.002_bib20","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/jnnp.2007.142950","article-title":"Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes","volume":"79","author":"Kanzaki","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.survophthal.2011.10.002_bib21","first-page":"932","article-title":"[High\u2013dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barr\u00e9 syndrome]","volume":"224","author":"Luke","year":"2007","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.survophthal.2011.10.002_bib22","first-page":"216","article-title":"[Optic retrobular neuritis in Guillain-Barr\u00e9 syndrome]","volume":"43","author":"Mouren","year":"1971","journal-title":"Rev Otoneuroophtalmol"},{"key":"10.1016\/j.survophthal.2011.10.002_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/WNL.43.4.842","article-title":"Guillain-Barr\u00e9 syndrome (GBS) with bilateral optic neuritis and central white matter disease","volume":"43","author":"Nadkarni","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2011.10.002_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1755-3768.1972.tb05647.x","article-title":"Retrobulbar neuritis as an early symptom of Guillain-Barr\u00e9 syndrome. report of a case","volume":"50","author":"Nikoskelainen","year":"1972","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.survophthal.2011.10.002_bib25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/jnnp.59.2.160","article-title":"Leber's \u201cplus\u201d: neurological abnormalities in patients with Leber's hereditary optic neuropathy","volume":"59","author":"Nikoskelainen","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.survophthal.2011.10.002_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/jnnp.70.1.50","article-title":"Anti\u2013GQ1b IgG antibody syndrome: Clinical and immunological range","volume":"70","author":"Odaka","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.survophthal.2011.10.002_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1468-1331.2002.00350.x","article-title":"Post-infectious central and peripheral nervous system diseases complicating Mycoplasma pneumoniae infection. Report of three cases and review of the literature","volume":"9","author":"Pfausler","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.survophthal.2011.10.002_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2011.10.002_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7861\/clinmedicine.10-4-399","article-title":"Guillain-Barr\u00e9 syndrome","volume":"10","author":"Pritchard","year":"2010","journal-title":"Clin Med"},{"key":"10.1016\/j.survophthal.2011.10.002_bib30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.clineuro.2008.12.005","article-title":"Optic neuritis and palatal dysarthria as presenting features of post-infectious GQ1b antibody syndrome","volume":"111","author":"Robbins","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.survophthal.2011.10.002_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11910-009-0055-0","article-title":"Neuro-ophthalmology and the anti-GQ1b antibody syndromes","volume":"9","author":"Saul","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.survophthal.2011.10.002_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2169\/internalmedicine.48.1585","article-title":"Bilateral retrobulbar optic neuritis, Guillain-Barr\u00e9 syndrome and asymptomatic central white matter lesions following adult measles infection","volume":"48","author":"Tomiyasu","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.survophthal.2011.10.002_bib33","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.survophthal.2011.10.002_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1517\/14728214.2011.531699","article-title":"Emerging drugs for Guillain-Barr\u00e9 syndrome","volume":"16","author":"Walgaard","year":"2011","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.survophthal.2011.10.002_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/jnnp.2009.176578","article-title":"When the Guillain-Barr\u00e9 patient fails to respond to treatment","volume":"9","author":"Winer","year":"2009","journal-title":"Pract Neurol"},{"key":"10.1016\/j.survophthal.2011.10.002_bib36","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2011.10.002_bib37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/PL00000714","article-title":"Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barr\u00e9 syndrome","volume":"57","author":"Yuki","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.survophthal.2011.10.002_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathies\u2014disease mechanisms and therapeutic strategies","volume":"30","author":"Yu-Wai-Man","year":"2011","journal-title":"Prog Retin Eye Res"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625711002116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625711002116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:37:35Z","timestamp":1758541055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625711002116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0039625711002116"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2011.10.002","relation":{},"ISSN":["0039-6257"],"issn-type":[{"type":"print","value":"0039-6257"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blindness, Weakness, and Tingling","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2011.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}